Anouncement #: PAR-15-031
Award Organization: NIH, NIBIB
Type/Mechanism: Federal/Reissue of RFA-EB-09-003-New, Renewal, Resubmission, Revision
Activity Code: U01 Research Project - Cooperative Agreements
Award Amount: Application budgets are not limited but it is strongly recommended that applicants not request a budget of more than $1,000,000 in direct costs per year.
PoP: 4 years
Restrictions: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Rolling Annual Program
Pre-proposal Due: December 12, 2017
Full Application Due: January 26, 2017
The goal of the National Institute of Biomedical Imaging and Bioengineering (NIBIB) Quantum Program is to achieve a profound (quantum) advance over present-day approaches to the prevention, detection, diagnosis, and/or treatment of a major disease or national public health problem primarily through the development of biomedical engineering/biomedical imaging technologies. In order to realize a profound advance against a major disease or national public health problem, this announcement supports research to develop and prepare a target technology for clinical efficacy at the completion of Quantum funding (which may include up to two competitive renewals).
The NIBIB mission is to improve human health by leading the development and acceleration of the application of biomedical technologies. Major biomedical technologies, emerging from the interface of the engineering, physical, and life sciences such as MR imaging, endoscopic devices for minimally invasive surgery, the cochlear implant, and the pacemaker have had a profound impact on human health and quality of life. In many cases, realization of a quantum impact from a new biomedical technology can only be achieved if the needed intellectual and financial resources are focused on a specific targeted project in a concerted fashion. The NIBIB Quantum Program is intended to support development of biomedical technologies that will result in a profound paradigm shift in prevention, detection, diagnosis, and/ or treatment of a major disease or national public health problem.